Skip to content

Confocal Laser Endomicroscopy Assisted Ultrasound Guided Pleural Biopsy

Diagnostic Yield and Safety of Probe-based COnfocaL LAser Endomicroscopy and Ultrasound-guided Pleural BiOpsy in Diagnosing Patients With Unknown pleuRAl Effusion: a Protocol of a Multicenter, Randomized cONtrolled Trial (COLLABORATION-Ⅱ)

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07040241
Acronym
Confocal laser
Enrollment
260
Registered
2025-06-27
Start date
2025-07-01
Completion date
2027-07-01
Last updated
2025-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural Effusion Disorder

Keywords

Pleural effusion, Confocal laser endomicroscopy, Pleural biopsy

Brief summary

This study aimed to evaluate the diagnostic yield and safety of confocal laser endomicroscopy and ultrasound-guided pleural biopsy in diagnosing patients with unknown pleural effusion.

Interventions

PROCEDUREConfocoal laser endomicroscopy-assisted ultrasound-guided pleural biopsy

Using the probe-based confocal laser endomicroscopy to detect the pleural, and ensure the biopsy location. Then, use the pleural biopsy tool to complete the pleural biopsy. The whole procession will under the ultrasound guidance.

Using ultrasound to detect the biopsy site and perform pleural biopsy.

Sponsors

China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients with exudative pleural effusion of unknown origin * Patients with negative pleural fluid cytology results * Patients diagnosed with a probable malignant pleural effusion but without a definite diagnosis and requiring further pathological evaluation * Patients who are fully informed of the purpose and method of the study, agree to participate in the study, and sign an informed consent form

Exclusion criteria

* Inability or refusal to undergo UGBx * Patients with any contraindications for pleural biopsy

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic yieldThe day 7 after patients received CLE-assisted ultrasound-guided pleural biopsy.The proportion of all individuals undergoing the diagnostic procedure under evaluation in whom a specific diagnosis is established based on the consensus definition.

Contacts

Primary ContactMingming Deng, Doctor
isdeng1017@163.com+86 18801336854

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026